دورية أكاديمية
أعرض في EDS

CC-486 (Oral Azacitidine) Maintenance Therapy Is Well Tolerated after Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML).

التفاصيل البيبلوغرافية
العنوان: CC-486 (Oral Azacitidine) Maintenance Therapy Is Well Tolerated after Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Patients with Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML).
المؤلفون: de Lima, Marcos1, Oran, Betul2, Papadopoulos, Esperanza B.3, Scott, Bart L.4, William, Basem M.5, Giralt, Sergio A.3, Champlin, Richard E.6, Hetzer, Joel7, Tosolini, Alessandra7, Laille, Eric7, Skikne, Barry S.7, Craddock, Charles8
المصدر: Biology of Blood & Marrow Transplantation. Mar2016 Supplement, Vol. 22, pS312-S313. 1p.
مصطلحات موضوعية: *HEMATOPOIETIC stem cell transplantation, *MYELODYSPLASTIC syndromes treatment, *ACUTE myeloid leukemia treatment, *HOMOGRAFTS, *AZACITIDINE, *HEMATOLOGY, *THERAPEUTICS
قاعدة البيانات: Academic Search Index
الوصف
تدمد:10838791
DOI:10.1016/j.bbmt.2015.11.784